17
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Intratumoral Production of IL-6 in B Cell Chronic Lymphocytic Leukemia and B Lymphomas

, , , , , , & show all
Pages 411-417 | Received 26 Mar 1993, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Zhifeng Yu, Baohua Sun, Hagop M. Kantarjian, Michael J. Keating, Hesham M. Amin & Xiaoping Sun. (2008) Protein expression profiling of cytokines and cytokine receptors on purified chronic lymphocytic leukemia cells from patients with favourable prognostic indicators. Leukemia & Lymphoma 49:4, pages 751-756.
Read now
E. Legouffe, C. Rodriguez, M. C. Picgt, B. Richard, B. Klein, J. F. Rossi & T. Commes. (1998) C-Reactive Protein Serum Level is a Valuable and Simple Prognostic Marker in Non Hodgkin's Lymphoma. Leukemia & Lymphoma 31:3-4, pages 351-357.
Read now

Articles from other publishers (10)

Susan A. Shinton, Joni Brill-Dashoff & Kyoko Hayakawa. (2022) Pla2g2a promotes innate Th2-type immunity lymphocytes to increase B1a cells. Scientific Reports 12:1.
Crossref
Yi-Xin Zou, Jia Qiao, Hua-Yuan Zhu, Rui-Nan Lu, Yi Xia, Lei Cao, Wei Wu, Hui Jin, Wen-Jie Liu, Jin-Hua Liang, Jia-Zhu Wu, Li Wang, Lei Fan, Wei Xu & Jian-Yong Li. (2019) Albumin-to-Fibrinogen Ratio as an Independent Prognostic Parameter in Untreated Chronic Lymphocytic Leukemia: A Retrospective Study of 191 Cases. Cancer Research and Treatment 51:2, pages 664-671.
Crossref
Kang Lu, Xiao-sheng Fang, Li-li Feng, Yu-jie Jiang, Xiang-xiang Zhou, Xin Liu, Pei-pei Li, Na Chen, Mei Ding, Na Wang, Jie Zhang & Xin Wang. (2015) The STAT3 inhibitor WP1066 reverses the resistance of chronic lymphocytic leukemia cells to histone deacetylase inhibitors induced by interleukin-6. Cancer Letters 359:2, pages 250-258.
Crossref
Delia Nelson, Scott Fisher & Bruce Robinson. (2014) The “Trojan Horse” Approach to Tumor Immunotherapy: Targeting the Tumor Microenvironment. Journal of Immunology Research 2014, pages 1-14.
Crossref
David S. Hong, Laura S. Angelo & Razelle Kurzrock. (2007) Interleukin‐6 and its receptor in cancer. Cancer 110:9, pages 1911-1928.
Crossref
Asher Chanan-Khan & Carl W Porter. (2006) Immunomodulating drugs for chronic lymphocytic leukaemia. The Lancet Oncology 7:6, pages 480-488.
Crossref
Georgios V. Georgakis & Anas Younes. 2005. Cytokines and Cancer. Cytokines and Cancer 69 102 .
Martin Rudwaleit, Fernando Elias, Tiina Humaljoki, Lucia Neure, Wolfgang Knauf, Harald Stein, Armin Distler, Joachim Sieper, Claudia Berek & J�rgen Braun. (1998) Overexpanded B cell clone mediating leukemic arthritis by abundant secretion of interleukin-1?: A case report. Arthritis & Rheumatism 41:9, pages 1695-1701.
Crossref
John Wijdenes, Peter C. Heinrich, Gerhard Müller‐Newen, Catherine Roche, Zong‐Jiang Gu, Claude Clément & Bernard Klein. (2005) Interleukin‐6 signal transducer gp130 has specific binding sites for different cytokines as determined by antagonistic and agonistic anti‐gp130 monoclonal antibodies. European Journal of Immunology 25:12, pages 3474-3481.
Crossref
M. Schuler, C. Huber & C. Peschel. (1995) Cytokines in the pathophysiology and treatment of chronic B-cell malignancies. Annals of Hematology 71:2, pages 57-63.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.